Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Sea Mild Biotechnology Co., Ltd. (7516) Income Statement

Sea Mild Biotechnology Co., Ltd. Income Statement

Last quarter (Q2 2026), Sea Mild Biotechnology Co., Ltd.'s total revenue was NT$196.02M, an increase of 44.16% from the same quarter last year. In Q2, Sea Mild Biotechnology Co., Ltd.'s net income was NT$2.99M. See Sea Mild Biotechnology Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 341.94MNT$ 318.82MNT$ 257.02MNT$ 202.65MNT$ 163.82M
NT$ 89.20MNT$ 91.28MNT$ 56.37MNT$ 28.06MNT$ 12.95M
NT$ 81.79MNT$ 69.00MNT$ 51.54MNT$ 48.18MNT$ 44.94M
Depreciation and AmortizationNT$ 23.40MNT$ 19.06MNT$ 14.48MNT$ 15.17MNT$ 20.84M
NT$ 30.81MNT$ 53.25MNT$ 21.58MNT$ -5.63MNT$ -20.33M
NT$ 7.41MNT$ 22.28MNT$ 4.83MNT$ -11.98MNT$ -31.99M
NT$ 1.38MNT$ 10.66MNT$ 1.30MNT$ -9.50MNT$ -10.01M
NT$ 8.79MNT$ 32.94MNT$ 6.13MNT$ -21.48MNT$ -41.99M
NT$ 8.22MNT$ 31.99MNT$ 6.19MNT$ -21.38MNT$ -52.05M
Per Share Metrics
Basic EPSNT$ 0.46NT$ 1.66NT$ 0.32NT$ -1.11NT$ -2.70
Diluted EPSNT$ 0.46NT$ 1.66NT$ 0.32NT$ -1.11NT$ -2.70
Weighted Average Shares Outstanding17.87M19.31M19.31M19.31M19.31M
Weighted Average Shares Outstanding (Diluted)17.87M19.31M19.31M19.31M19.31M

Currency in TWD

Sea Mild Biotechnology Co., Ltd. Earnings and Revenue History

-200M0200M400M-80 %-40 %0 %40 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin